GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Mainz Biomed NV (NAS:MYNZ) » Definitions » Price-to-Owner-Earnings

Mainz Biomed NV (Mainz Biomed NV) Price-to-Owner-Earnings : (As of May. 19, 2024)


View and export this data going back to 2021. Start your Free Trial

What is Mainz Biomed NV Price-to-Owner-Earnings?

As of today (2024-05-19), Mainz Biomed NV's share price is $0.6799. Mainz Biomed NV does not have enough data to calculate Owner Earnings per Share (TTM), so as pPrice-to-Owner-Earnings.


The historical rank and industry rank for Mainz Biomed NV's Price-to-Owner-Earnings or its related term are showing as below:


MYNZ's Price-to-Owner-Earnings is not ranked *
in the Medical Diagnostics & Research industry.
Industry Median: 24.85
* Ranked among companies with meaningful Price-to-Owner-Earnings only.

As of today (2024-05-19), Mainz Biomed NV's share price is $0.6799. Mainz Biomed NV's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was $-1.64. Therefore, Mainz Biomed NV's PE Ratio for today is At Loss.

As of today (2024-05-19), Mainz Biomed NV's share price is $0.6799. Mainz Biomed NV's EPS without NRI for the trailing twelve months (TTM) ended in was $-1.64. Therefore, Mainz Biomed NV's PE Ratio without NRI for today is At Loss.


Mainz Biomed NV Price-to-Owner-Earnings Historical Data

The historical data trend for Mainz Biomed NV's Price-to-Owner-Earnings can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Mainz Biomed NV Price-to-Owner-Earnings Chart

Mainz Biomed NV Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
Price-to-Owner-Earnings
- - - - -

Mainz Biomed NV Quarterly Data
Dec19 Jun20 Dec20 Jun21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Price-to-Owner-Earnings Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Mainz Biomed NV's Price-to-Owner-Earnings

For the Diagnostics & Research subindustry, Mainz Biomed NV's Price-to-Owner-Earnings, along with its competitors' market caps and Price-to-Owner-Earnings data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Mainz Biomed NV's Price-to-Owner-Earnings Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Mainz Biomed NV's Price-to-Owner-Earnings distribution charts can be found below:

* The bar in red indicates where Mainz Biomed NV's Price-to-Owner-Earnings falls into.



Mainz Biomed NV Price-to-Owner-Earnings Calculation

In 1986 Berkshire Hathaway Shareholder Letter, Warren Buffett defined owner earnings as follows:

"These represent (a) reported earnings plus (b) depreciation, depletion, amortization, and certain other non-cash charges...less (c) the average annual amount of capitalized expenditures for plant and equipment, etc. that the business requires to fully maintain its long-term competitive position and its unit volume. (If the business requires additional working capital to maintain its competitive position and unit volume, the increment also should be included in (c))...Our owner-earnings equation does not yield the deceptively precise figures provided by GAAP, since (c) must be a guess - and one sometimes very difficult to make. Despite this problem, we consider the owner earnings figure, not the GAAP figure, to be the relevant item for valuation purposes - both for investors in buying stocks and for managers in buying entire businesses...All of this points up the absurdity of the 'cash flow' numbers that are often set forth in Wall Street reports. These numbers routinely include (a) plus (b) - but do not subtract (c)."

Mainz Biomed NV's Price-to-Owner-Earnings for today is calculated as

Price-to-Owner-Earnings=Share Price/Owner Earnings per Share (TTM)
=0.6799/0.00
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Mainz Biomed NV  (NAS:MYNZ) Price-to-Owner-Earnings Explanation

For how to get Owner Earnings per Share (TTM), please click.


Mainz Biomed NV Price-to-Owner-Earnings Related Terms

Thank you for viewing the detailed overview of Mainz Biomed NV's Price-to-Owner-Earnings provided by GuruFocus.com. Please click on the following links to see related term pages.


Mainz Biomed NV (Mainz Biomed NV) Business Description

Traded in Other Exchanges
Address
Robert Koch Strasse 5, Sirius Gutenberg Park, Mainz, RP, DEU, 55129
Mainz Biomed NV is engaged in developing molecular genetic diagnostic solutions for life-threatening conditions. Its main product Coloalert is a kit that includes a stool collector and shipping instructions to return the kit through regular mail to their local lab for testing and results.